Alycia Halladay is chief science officer of the Autism Science Foundation.
![](https://www.thetransmitter.org/wp-content/uploads/2015/12/AlyciaHalladay.jpg)
Alycia Halladay
Chief science officer
Autism Science Foundation
From this contributor
New program offers $35K grants to study ‘profound autism’
People who have ‘profound autism’ — those with severe intellectual disability, limited communication abilities or both — tend to be excluded from research. The Autism Science Foundation seeks to change that.
![An abstract "funding mechanism" featuring dollar bills alongside tubes, beakers and wires](https://www.thetransmitter.org/wp-content/uploads/2022/07/Funding-mechanism-asf-autism-844.jpg)
New program offers $35K grants to study ‘profound autism’
Questions for Amaral, Halladay: Boosting brainpower
A new network of brain banks aims to collect and disburse tissue donations to U.S. autism researchers.
![](https://www.thetransmitter.org/wp-content/uploads/2015/12/20151215BrainNetQA-844-2.jpg)
Questions for Amaral, Halladay: Boosting brainpower
Explore more from The Transmitter
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
![](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200_coughingmice-1024x720.webp)
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
![Capitol building](https://www.thetransmitter.org/wp-content/uploads/2024/09/capitolhill-1200-1024x692.webp)
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.
![Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200-ketamine-receptor-transmitter-neuroscience-1024x683.webp)
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.